Literature DB >> 8254734

Proteolytic activity of novel human immunodeficiency virus type 1 proteinase proteins from a precursor with a blocking mutation at the N terminus of the PR domain.

G Zybarth1, H G Kräusslich, K Partin, C Carter.   

Abstract

The mature human immunodeficiency virus type 1 proteinase (PR; 11 kDa) can cleave all interdomain junctions in the Gag and Gag-Pol polyprotein precursors. To determine the activity of the enzyme in its precursor form, we blocked release of mature PR from a truncated Gag-Pol polyprotein by introducing mutations into the N-terminal Phe-Pro cleavage site of the PR domain. The mutant precursor autoprocessed efficiently upon expression in Escherichia coli. No detectable mature PR was released; however, several PR-related products ranging in size from approximately 14 to 18 kDa accumulated. Products of the same size were generated when mutant precursors were digested with wild-type PR. Thus, PR can utilize cleavage sites in the region upstream of the PR domain, resulting in the formation of extended PR species. On the basis of active-site titration, the PR species generated from mutated precursor exhibited wild-type activity on peptide substrates. However, the proteolytic activity of these extended enzymes on polyprotein substrates provided exogenously was low when equimolar amounts of extended and wild-type PR proteins were compared. Mammalian cells expressing the mutated precursor produced predominantly precursor and considerably reduced amounts of mature products. Released particles consisted mostly of uncleaved or partially cleaved polyproteins. Our results suggest that precursor forms of PR can autoprocess but are less efficient in processing of the Gag precursor for formation of mature virus particles.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8254734      PMCID: PMC236283     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments.

Authors:  A H Kaplan; R Swanstrom
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

2.  HIV-1 reproduction is inhibited by peptides derived frm the N- and C-termini of HIV-1 protease.

Authors:  H J Schramm; H Nakashima; W Schramm; H Wakayama; N Yamamoto
Journal:  Biochem Biophys Res Commun       Date:  1991-09-16       Impact factor: 3.575

3.  Autoprocessing of the HIV-1 protease using purified wild-type and mutated fusion proteins expressed at high levels in Escherichia coli.

Authors:  J M Louis; R A McDonald; N T Nashed; E M Wondrak; D M Jerina; S Oroszlan; P T Mora
Journal:  Eur J Biochem       Date:  1991-07-15

4.  Deletion of sequences upstream of the proteinase improves the proteolytic processing of human immunodeficiency virus type 1.

Authors:  K Partin; G Zybarth; L Ehrlich; M DeCrombrugghe; E Wimmer; C Carter
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

Review 5.  Structure and function of retroviral proteases.

Authors:  P M Fitzgerald; J P Springer
Journal:  Annu Rev Biophys Biophys Chem       Date:  1991

6.  Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the P1 amino acid.

Authors:  S C Pettit; J Simsic; D D Loeb; L Everitt; C A Hutchison; R Swanstrom
Journal:  J Biol Chem       Date:  1991-08-05       Impact factor: 5.157

7.  Dissociative inhibition of dimeric enzymes. Kinetic characterization of the inhibition of HIV-1 protease by its COOH-terminal tetrapeptide.

Authors:  Z Y Zhang; R A Poorman; L L Maggiora; R L Heinrikson; F J Kézdy
Journal:  J Biol Chem       Date:  1991-08-25       Impact factor: 5.157

8.  Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag-Pol polyproteins.

Authors:  J Tözsér; I Bláha; T D Copeland; E M Wondrak; S Oroszlan
Journal:  FEBS Lett       Date:  1991-04-09       Impact factor: 4.124

9.  Expression in Escherichia coli and purification of human immunodeficiency virus type 1 capsid protein (p24).

Authors:  L S Ehrlich; H G Krausslich; E Wimmer; C A Carter
Journal:  AIDS Res Hum Retroviruses       Date:  1990-10       Impact factor: 2.205

10.  Human immunodeficiency virus protease. Bacterial expression and characterization of the purified aspartic protease.

Authors:  P L Darke; C T Leu; L J Davis; J C Heimbach; R E Diehl; W S Hill; R A Dixon; I S Sigal
Journal:  J Biol Chem       Date:  1989-02-05       Impact factor: 5.157

View more
  24 in total

1.  Reversal by dithiothreitol treatment of the block in murine leukemia virus maturation induced by disulfide cross-linking.

Authors:  Stephen Campbell; Masamichi Oshima; Jane Mirro; Kunio Nagashima; Alan Rein
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

2.  Assembly and processing of human immunodeficiency virus Gag mutants containing a partial replacement of the matrix domain by the viral protease domain.

Authors:  C T Wang; Y C Chou; C C Chiang
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Uncoupling human immunodeficiency virus type 1 Gag and Pol reading frames: role of the transframe protein p6* in viral replication.

Authors:  Andreas Leiherer; Christine Ludwig; Ralf Wagner
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

4.  Altered gag polyprotein cleavage specificity of feline immunodeficiency virus/human immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system.

Authors:  Ying-Chuan Lin; Ashraf Brik; Aymeric de Parseval; Karen Tam; Bruce E Torbett; Chi-Huey Wong; John H Elder
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

5.  Altered Rous sarcoma virus Gag polyprotein processing and its effects on particle formation.

Authors:  Y Xiang; T W Ridky; N K Krishna; J Leis
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

6.  Analysis of cleavage site mutations between the NC and PR Gag domains of Rous sarcoma virus.

Authors:  G Schatz; I Pichova; V M Vogt
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

7.  HIV-1 protease inhibits its homologous reverse transcriptase by protein-protein interaction.

Authors:  M Böttcher; F Grosse
Journal:  Nucleic Acids Res       Date:  1997-05-01       Impact factor: 16.971

8.  Virion instability of human immunodeficiency virus type 1 reverse transcriptase (RT) mutated in the protease cleavage site between RT p51 and the RT RNase H domain.

Authors:  Michael E Abram; Michael A Parniak
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Importance of the N terminus of rous sarcoma virus protease for structure and enzymatic function.

Authors:  G W Schatz; J Reinking; J Zippin; L K Nicholson; V M Vogt
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

Review 10.  The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences.

Authors:  R Löwer; J Löwer; R Kurth
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.